| Number | GOID | Name | p-value | FDR(GOSSIP) |
FWER(GOSSIP) | Holm | Sidak | BH | BY | Bonferoni |
| 1 | 279 | M phase | 0 | 9.5e-09 | 1.2e-08 | 0 | 0 | 0 | 0 | 0 |
| 2 | 87 | M phase of mitotic cell cycle | 0 | 9.5e-09 | 1.2e-08 | 0 | 0 | 0 | 0 | 0 |
| 3 | 7067 | mitosis | 0 | 9.5e-09 | 1.2e-08 | 0 | 0 | 0 | 0 | 0 |
| 4 | 280 | nuclear division | 1.9e-13 | 9.5e-09 | 1.2e-08 | 8.4e-11 | 8.4e-11 | 2.1e-11 | 1.4e-10 | 8.4e-11 |
| 5 | 7049 | cell cycle | 2.5e-12 | 9.5e-09 | 1.2e-08 | 1.1e-09 | 1.1e-09 | 2.2e-10 | 1.5e-09 | 1.1e-09 |
| 6 | 278 | mitotic cell cycle | 1.3e-11 | 9.5e-09 | 1.4e-08 | 5.4e-09 | 5.4e-09 | 9.1e-10 | 6.1e-09 | 5.5e-09 |
| 7 | 8283 | cell proliferation | 1.9e-09 | 1.9e-07 | 3.2e-07 | 8.2e-07 | 8.2e-07 | 1.2e-07 | 7.9e-07 | 8.3e-07 |
| 8 | 74 | regulation of cell cycle | 4.2e-08 | 3.4e-06 | 6.8e-06 | 1.8e-05 | 1.8e-05 | 2.3e-06 | 1.5e-05 | 1.8e-05 |
| 9 | 910 | cytokinesis | 7.2e-08 | 5.1e-06 | 1.2e-05 | 3.1e-05 | 3.1e-05 | 3.5e-06 | 2.3e-05 | 3.1e-05 |
| 10 | 15630 | microtubule cytoskeleton | 1.8e-07 | 1.7e-05 | 4.3e-05 | 7.5e-05 | 7.5e-05 | 7.6e-06 | 5.1e-05 | 7.6e-05 |
| 11 | 7017 | microtubule-based process | 3.4e-07 | 2.4e-05 | 6.7e-05 | 0.00014 | 0.00014 | 1.3e-05 | 8.8e-05 | 0.00015 |
| 12 | 70 | mitotic chromosome segregation | 8.6e-07 | 6.7e-05 | 0.0002 | 0.00036 | 0.00036 | 3.1e-05 | 0.00021 | 0.00037 |
| 13 | 5634 | nucleus | 1.2e-06 | 7.4e-05 | 0.00024 | 0.00051 | 0.00051 | 4e-05 | 0.00027 | 0.00052 |
| 14 | 5874 | microtubule | 1.8e-06 | 0.00012 | 0.0004 | 0.00076 | 0.00076 | 5.6e-05 | 0.00037 | 0.00078 |
| 15 | 7088 | regulation of mitosis | 2.1e-06 | 0.00012 | 0.00044 | 0.00087 | 0.00087 | 6e-05 | 0.0004 | 0.0009 |
| 16 | 90 | mitotic anaphase | 5e-06 | 0.00023 | 0.0009 | 0.0021 | 0.0021 | 0.00014 | 0.0009 | 0.0022 |
| 17 | 5694 | chromosome | 8.7e-06 | 0.00035 | 0.0015 | 0.0037 | 0.0036 | 0.00022 | 0.0015 | 0.0038 |
| 18 | 7018 | microtubule-based movement | 1.1e-05 | 0.00043 | 0.002 | 0.0046 | 0.0046 | 0.00025 | 0.0017 | 0.0048 |
| 19 | 30705 | cytoskeleton-dependent intracellular transport | 1.1e-05 | 0.00043 | 0.002 | 0.0046 | 0.0046 | 0.00025 | 0.0017 | 0.0048 |
| 20 | 7093 | mitotic checkpoint | 3.5e-05 | 0.0023 | 0.011 | 0.015 | 0.015 | 0.00077 | 0.0051 | 0.015 |
| 21 | 5622 | intracellular | 4.4e-05 | 0.0024 | 0.012 | 0.018 | 0.018 | 0.00091 | 0.0061 | 0.019 |
| 22 | 67 | DNA replication and chromosome cycle | 6.7e-05 | 0.0028 | 0.016 | 0.028 | 0.027 | 0.0013 | 0.0088 | 0.029 |
| 23 | 7059 | chromosome segregation | 7e-05 | 0.0028 | 0.016 | 0.029 | 0.029 | 0.0013 | 0.0088 | 0.031 |
| 24 | 8151 | cell growth and/or maintenance | 7.9e-05 | 0.0029 | 0.017 | 0.033 | 0.032 | 0.0014 | 0.0096 | 0.034 |
| 25 | 75 | cell cycle checkpoint | 0.00014 | 0.0058 | 0.036 | 0.059 | 0.058 | 0.0025 | 0.017 | 0.063 |
| 26 | 7010 | cytoskeleton organization and biogenesis | 0.00021 | 0.0091 | 0.057 | 0.084 | 0.08 | 0.0034 | 0.023 | 0.089 |
| 27 | 5856 | cytoskeleton | 0.00024 | 0.0094 | 0.062 | 0.098 | 0.093 | 0.0039 | 0.026 | 0.1 |
| 28 | 30261 | chromosome condensation | 0.00027 | 0.0098 | 0.066 | 0.11 | 0.11 | 0.0042 | 0.028 | 0.12 |
| 29 | 42267 | natural killer cell mediated cytolysis | 0.0003 | 0.011 | 0.085 | 0.12 | 0.12 | 0.0043 | 0.028 | 0.13 |
| 30 | 3683 | lamin/chromatin binding | 0.0003 | 0.011 | 0.085 | 0.12 | 0.12 | 0.0043 | 0.028 | 0.13 |
| 31 | 45298 | tubulin | 0.0003 | 0.011 | 0.085 | 0.12 | 0.12 | 0.0043 | 0.028 | 0.13 |
| 32 | 5819 | spindle | 0.00037 | 0.012 | 0.093 | 0.15 | 0.14 | 0.005 | 0.033 | 0.16 |
| 33 | 7089 | start control point of mitotic cell cycle | 0.00063 | 0.02 | 0.16 | 0.25 | 0.22 | 0.0081 | 0.054 | 0.27 |
| 34 | 16043 | cell organization and biogenesis | 0.00063 | 0.02 | 0.16 | 0.25 | 0.22 | 0.0081 | 0.054 | 0.28 |
| 35 | 785 | chromatin | 0.00088 | 0.025 | 0.2 | 0.35 | 0.3 | 0.011 | 0.072 | 0.38 |
| 36 | 775 | chromosome, pericentric region | 0.00096 | 0.025 | 0.21 | 0.38 | 0.32 | 0.012 | 0.077 | 0.42 |
| 37 | 6996 | organelle organization and biogenesis | 0.001 | 0.025 | 0.21 | 0.4 | 0.33 | 0.012 | 0.078 | 0.43 |
| 38 | 88 | mitotic prophase | 0.0011 | 0.027 | 0.24 | 0.43 | 0.35 | 0.012 | 0.078 | 0.47 |
| 39 | 5521 | lamin binding | 0.0011 | 0.027 | 0.24 | 0.43 | 0.35 | 0.012 | 0.078 | 0.47 |
| 40 | 7076 | mitotic chromosome condensation | 0.0011 | 0.027 | 0.24 | 0.43 | 0.35 | 0.012 | 0.078 | 0.47 |
| 41 | 9987 | cellular process | 0.0012 | 0.028 | 0.25 | 0.48 | 0.38 | 0.013 | 0.087 | 0.53 |
| 42 | 5813 | centrosome | 0.0015 | 0.032 | 0.29 | 0.6 | 0.45 | 0.015 | 0.1 | 0.66 |
| 43 | 7050 | cell cycle arrest | 0.0015 | 0.032 | 0.29 | 0.6 | 0.45 | 0.015 | 0.1 | 0.66 |
| 44 | 4861 | cyclin-dependent protein kinase inhibitor activity | 0.0016 | 0.034 | 0.32 | 0.64 | 0.47 | 0.016 | 0.1 | 0.71 |
| 45 | 5099 | Ras GTPase activator activity | 0.0016 | 0.034 | 0.32 | 0.64 | 0.47 | 0.016 | 0.1 | 0.71 |
| 46 | 922 | spindle pole | 0.0021 | 0.04 | 0.38 | 0.83 | 0.56 | 0.02 | 0.13 | 0.93 |
| 47 | 786 | nucleosome | 0.0021 | 0.04 | 0.38 | 0.83 | 0.56 | 0.02 | 0.13 | 0.93 |
| 48 | 17076 | purine nucleotide binding | 0.0024 | 0.042 | 0.4 | 0.93 | 0.61 | 0.021 | 0.14 | 1 |
| 49 | 7028 | cytoplasm organization and biogenesis | 0.0024 | 0.042 | 0.4 | 0.93 | 0.61 | 0.021 | 0.14 | 1 |
| 50 | 5815 | microtubule organizing center | 0.0024 | 0.042 | 0.41 | 0.93 | 0.61 | 0.021 | 0.14 | 1 |
| 51 | 166 | nucleotide binding | 0.0027 | 0.046 | 0.44 | 1 | 0.65 | 0.023 | 0.15 | 1 |
| 52 | 42288 | MHC class I protein binding | 0.0031 | 0.05 | 0.48 | 1 | 0.69 | 0.026 | 0.17 | 1 |
| 53 | 6334 | nucleosome assembly | 0.0043 | 0.062 | 0.56 | 1 | 0.81 | 0.034 | 0.22 | 1 |
| 54 | 7051 | spindle assembly | 0.0044 | 0.062 | 0.58 | 1 | 0.82 | 0.034 | 0.22 | 1 |
| 55 | 7052 | mitotic spindle assembly | 0.0044 | 0.062 | 0.58 | 1 | 0.82 | 0.034 | 0.22 | 1 |
| 56 | 42287 | MHC protein binding | 0.0044 | 0.062 | 0.58 | 1 | 0.82 | 0.034 | 0.22 | 1 |
| 57 | 19835 | cytolysis | 0.0044 | 0.062 | 0.58 | 1 | 0.82 | 0.034 | 0.22 | 1 |
| 58 | 226 | microtubule cytoskeleton organization and biogenesis | 0.0052 | 0.068 | 0.63 | 1 | 0.86 | 0.035 | 0.23 | 1 |
| 59 | 4693 | cyclin-dependent protein kinase activity | 0.0055 | 0.071 | 0.65 | 1 | 0.87 | 0.035 | 0.23 | 1 |
| 60 | 3717 | Pol II transcription termination factor activity | 0.0056 | 0.14 | 0.91 | 1 | 0.88 | 0.035 | 0.23 | 1 |
| 61 | 40001 | mitotic spindle positioning and orientation | 0.0056 | 0.14 | 0.91 | 1 | 0.88 | 0.035 | 0.23 | 1 |
| 62 | 7063 | regulation of sister chromatid cohesion | 0.0056 | 0.14 | 0.91 | 1 | 0.88 | 0.035 | 0.23 | 1 |
| 63 | 45875 | negative regulation of sister chromatid cohesion | 0.0056 | 0.14 | 0.91 | 1 | 0.88 | 0.035 | 0.23 | 1 |
| 64 | 30071 | regulation of mitotic metaphase/anaphase transition | 0.0056 | 0.14 | 0.91 | 1 | 0.88 | 0.035 | 0.23 | 1 |
| 65 | 45842 | positive regulation of mitotic metaphase/anaphase transition | 0.0056 | 0.14 | 0.91 | 1 | 0.88 | 0.035 | 0.23 | 1 |
| 66 | 7095 | mitotic G2 checkpoint | 0.0056 | 0.14 | 0.91 | 1 | 0.88 | 0.035 | 0.23 | 1 |
| 67 | 45840 | positive regulation of mitosis | 0.0056 | 0.14 | 0.91 | 1 | 0.88 | 0.035 | 0.23 | 1 |
| 68 | 45787 | positive regulation of cell cycle | 0.0056 | 0.14 | 0.91 | 1 | 0.88 | 0.035 | 0.23 | 1 |
| 69 | 9387 | DNA supercoiling activity | 0.0056 | 0.14 | 0.91 | 1 | 0.88 | 0.035 | 0.23 | 1 |
| 70 | 80 | G1 phase of mitotic cell cycle | 0.0066 | 0.15 | 0.93 | 1 | 0.91 | 0.041 | 0.27 | 1 |
| 71 | 5525 | GTP binding | 0.0067 | 0.15 | 0.93 | 1 | 0.91 | 0.041 | 0.27 | 1 |
| 72 | 19001 | guanyl nucleotide binding | 0.0071 | 0.15 | 0.93 | 1 | 0.92 | 0.043 | 0.28 | 1 |
| 73 | 72 | M-phase specific microtubule process | 0.011 | 0.17 | 0.96 | 1 | 0.98 | 0.063 | 0.42 | 1 |
| 74 | 796 | condensin complex | 0.011 | 0.27 | 0.99 | 1 | 0.98 | 0.063 | 0.42 | 1 |
| 75 | 45494 | photoreceptor maintenance | 0.011 | 0.27 | 0.99 | 1 | 0.98 | 0.063 | 0.42 | 1 |
| 76 | 3918 | DNA topoisomerase (ATP-hydrolyzing) activity | 0.011 | 0.27 | 0.99 | 1 | 0.98 | 0.063 | 0.42 | 1 |
| 77 | 8455 | alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity | 0.011 | 0.27 | 0.99 | 1 | 0.98 | 0.063 | 0.42 | 1 |
| 78 | 4860 | protein kinase inhibitor activity | 0.013 | 0.27 | 1 | 1 | 0.99 | 0.071 | 0.47 | 1 |
| 79 | 776 | kinetochore | 0.013 | 0.27 | 1 | 1 | 0.99 | 0.071 | 0.47 | 1 |
| 80 | 19210 | kinase inhibitor activity | 0.016 | 0.29 | 1 | 1 | 1 | 0.082 | 0.55 | 1 |
| 81 | 42572 | retinol metabolism | 0.017 | 0.35 | 1 | 1 | 1 | 0.082 | 0.55 | 1 |
| 82 | 7094 | mitotic spindle checkpoint | 0.017 | 0.35 | 1 | 1 | 1 | 0.082 | 0.55 | 1 |
| 83 | 6726 | eye pigment biosynthesis | 0.017 | 0.35 | 1 | 1 | 1 | 0.082 | 0.55 | 1 |
| 84 | 42441 | eye pigment metabolism | 0.017 | 0.35 | 1 | 1 | 1 | 0.082 | 0.55 | 1 |
| 85 | 7261 | STAT protein dimerization | 0.017 | 0.35 | 1 | 1 | 1 | 0.082 | 0.55 | 1 |
| 86 | 22 | mitotic spindle elongation | 0.017 | 0.35 | 1 | 1 | 1 | 0.082 | 0.55 | 1 |
| 87 | 5814 | centriole | 0.017 | 0.35 | 1 | 1 | 1 | 0.082 | 0.55 | 1 |
| 88 | 3715 | transcription termination factor activity | 0.017 | 0.35 | 1 | 1 | 1 | 0.082 | 0.55 | 1 |
| 89 | 228 | nuclear chromosome | 0.022 | 0.37 | 1 | 1 | 1 | 0.1 | 0.66 | 1 |
| 90 | 4905 | interferon-alpha/beta receptor activity | 0.022 | 0.42 | 1 | 1 | 1 | 0.1 | 0.66 | 1 |
| 91 | 6353 | transcription termination | 0.022 | 0.42 | 1 | 1 | 1 | 0.1 | 0.66 | 1 |
| 92 | 46658 | extrinsic to plasma membrane, GPI-anchored | 0.022 | 0.42 | 1 | 1 | 1 | 0.1 | 0.66 | 1 |
| 93 | 7091 | mitotic metaphase/anaphase transition | 0.022 | 0.42 | 1 | 1 | 1 | 0.1 | 0.66 | 1 |
| 94 | 6449 | regulation of translational termination | 0.022 | 0.42 | 1 | 1 | 1 | 0.1 | 0.66 | 1 |
| 95 | 19962 | interferon-alpha/beta binding | 0.022 | 0.42 | 1 | 1 | 1 | 0.1 | 0.66 | 1 |
| 96 | 8054 | cyclin catabolism | 0.022 | 0.42 | 1 | 1 | 1 | 0.1 | 0.66 | 1 |
| 97 | 5875 | microtubule associated complex | 0.024 | 0.43 | 1 | 1 | 1 | 0.11 | 0.72 | 1 |
| 98 | 6333 | chromatin assembly/disassembly | 0.026 | 0.43 | 1 | 1 | 1 | 0.11 | 0.76 | 1 |
| 99 | 4745 | retinol dehydrogenase activity | 0.028 | 0.47 | 1 | 1 | 1 | 0.11 | 0.76 | 1 |
| 100 | 6744 | ubiquinone biosynthesis | 0.028 | 0.47 | 1 | 1 | 1 | 0.11 | 0.76 | 1 |
| 101 | 45426 | quinone cofactor biosynthesis | 0.028 | 0.47 | 1 | 1 | 1 | 0.11 | 0.76 | 1 |
| 102 | 45749 | negative regulation of S phase of mitotic cell cycle | 0.028 | 0.47 | 1 | 1 | 1 | 0.11 | 0.76 | 1 |
| 103 | 45930 | negative regulation of mitotic cell cycle | 0.028 | 0.47 | 1 | 1 | 1 | 0.11 | 0.76 | 1 |
| 104 | 6743 | ubiquinone metabolism | 0.028 | 0.47 | 1 | 1 | 1 | 0.11 | 0.76 | 1 |
| 105 | 42375 | quinone cofactor metabolism | 0.028 | 0.47 | 1 | 1 | 1 | 0.11 | 0.76 | 1 |
| 106 | 6259 | DNA metabolism | 0.029 | 0.47 | 1 | 1 | 1 | 0.12 | 0.78 | 1 |
| 107 | 5635 | nuclear membrane | 0.032 | 0.48 | 1 | 1 | 1 | 0.13 | 0.85 | 1 |
| 108 | 7262 | STAT protein nuclear translocation | 0.033 | 0.51 | 1 | 1 | 1 | 0.13 | 0.85 | 1 |
| 109 | 48069 | eye pigmentation | 0.033 | 0.51 | 1 | 1 | 1 | 0.13 | 0.85 | 1 |
| 110 | 5072 | transforming growth factor beta receptor, cytoplasmic mediator activity | 0.033 | 0.51 | 1 | 1 | 1 | 0.13 | 0.85 | 1 |
| 111 | 5071 | transmembrane receptor protein serine/threonine kinase signaling protein activity | 0.033 | 0.51 | 1 | 1 | 1 | 0.13 | 0.85 | 1 |
| 112 | 5062 | hematopoietin/interferon-class (D200-domain) cytokine receptor signal transducer activity | 0.033 | 0.51 | 1 | 1 | 1 | 0.13 | 0.85 | 1 |
| 113 | 7259 | JAK-STAT cascade | 0.035 | 0.52 | 1 | 1 | 1 | 0.14 | 0.9 | 1 |
| 114 | 6265 | DNA topological change | 0.038 | 0.54 | 1 | 1 | 1 | 0.14 | 0.91 | 1 |
| 115 | 4904 | interferon receptor activity | 0.038 | 0.54 | 1 | 1 | 1 | 0.14 | 0.91 | 1 |
| 116 | 19961 | interferon binding | 0.038 | 0.54 | 1 | 1 | 1 | 0.14 | 0.91 | 1 |
| 117 | 16873 | other isomerase activity | 0.038 | 0.54 | 1 | 1 | 1 | 0.14 | 0.91 | 1 |
| 118 | 3916 | DNA topoisomerase activity | 0.038 | 0.54 | 1 | 1 | 1 | 0.14 | 0.91 | 1 |
| 119 | 7346 | regulation of mitotic cell cycle | 0.038 | 0.54 | 1 | 1 | 1 | 0.14 | 0.91 | 1 |
| 120 | 6775 | fat-soluble vitamin metabolism | 0.038 | 0.54 | 1 | 1 | 1 | 0.14 | 0.91 | 1 |
| 121 | 6776 | vitamin A metabolism | 0.038 | 0.54 | 1 | 1 | 1 | 0.14 | 0.91 | 1 |
| 122 | 7090 | regulation of S phase of mitotic cell cycle | 0.038 | 0.54 | 1 | 1 | 1 | 0.14 | 0.91 | 1 |
| 123 | 3777 | microtubule motor activity | 0.039 | 0.54 | 1 | 1 | 1 | 0.14 | 0.91 | 1 |
| 124 | 79 | regulation of CDK activity | 0.041 | 0.54 | 1 | 1 | 1 | 0.15 | 0.97 | 1 |
| 125 | 6415 | translational termination | 0.044 | 0.58 | 1 | 1 | 1 | 0.15 | 1 | 1 |
| 126 | 7062 | sister chromatid cohesion | 0.049 | 0.64 | 1 | 1 | 1 | 0.17 | 1 | 1 |
| 127 | 8023 | transcription elongation factor complex | 0.049 | 0.64 | 1 | 1 | 1 | 0.17 | 1 | 1 |
| 128 | 86 | G2/M transition of mitotic cell cycle | 0.051 | 0.64 | 1 | 1 | 1 | 0.17 | 1 | 1 |
| 129 | 5524 | ATP binding | 0.053 | 0.64 | 1 | 1 | 1 | 0.18 | 1 | 1 |
| 130 | 16012 | sarcoglycan complex | 0.054 | 0.65 | 1 | 1 | 1 | 0.18 | 1 | 1 |
| 131 | 16011 | dystroglycan complex | 0.054 | 0.65 | 1 | 1 | 1 | 0.18 | 1 | 1 |
| 132 | 5680 | anaphase-promoting complex | 0.054 | 0.65 | 1 | 1 | 1 | 0.18 | 1 | 1 |
| 133 | 45898 | regulation of transcriptional preinitiation complex formation | 0.054 | 0.65 | 1 | 1 | 1 | 0.18 | 1 | 1 |
| 134 | 152 | nuclear ubiquitin ligase complex | 0.054 | 0.65 | 1 | 1 | 1 | 0.18 | 1 | 1 |
| 135 | 30554 | adenyl nucleotide binding | 0.058 | 0.66 | 1 | 1 | 1 | 0.19 | 1 | 1 |
| 136 | 19887 | protein kinase regulator activity | 0.058 | 0.66 | 1 | 1 | 1 | 0.19 | 1 | 1 |
| 137 | 50789 | regulation of biological process | 0.065 | 0.7 | 1 | 1 | 1 | 0.2 | 1 | 1 |
| 138 | 19207 | kinase regulator activity | 0.066 | 0.73 | 1 | 1 | 1 | 0.21 | 1 | 1 |
| 139 | 5096 | GTPase activator activity | 0.067 | 0.73 | 1 | 1 | 1 | 0.21 | 1 | 1 |
| 140 | 7001 | chromosome organization and biogenesis (sensu Eukarya) | 0.069 | 0.73 | 1 | 1 | 1 | 0.21 | 1 | 1 |
| 141 | 5639 | integral to nuclear inner membrane | 0.07 | 0.75 | 1 | 1 | 1 | 0.21 | 1 | 1 |
| 142 | 77 | DNA damage response, signal transduction resulting in cell cycle arrest | 0.07 | 0.75 | 1 | 1 | 1 | 0.21 | 1 | 1 |
| 143 | 9311 | oligosaccharide metabolism | 0.07 | 0.75 | 1 | 1 | 1 | 0.21 | 1 | 1 |
| 144 | 8285 | negative regulation of cell proliferation | 0.071 | 0.75 | 1 | 1 | 1 | 0.21 | 1 | 1 |
| 145 | 6997 | nuclear organization and biogenesis | 0.075 | 0.75 | 1 | 1 | 1 | 0.22 | 1 | 1 |
| 146 | 30183 | B-cell differentiation | 0.075 | 0.77 | 1 | 1 | 1 | 0.22 | 1 | 1 |
| 147 | 6260 | DNA replication | 0.083 | 0.8 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 148 | 84 | S phase of mitotic cell cycle | 0.084 | 0.8 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 149 | 9595 | perception of biotic stimulus | 0.086 | 0.81 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 150 | 9596 | perception of pest/pathogen/parasite | 0.086 | 0.81 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 151 | 50790 | regulation of enzyme activity | 0.086 | 0.81 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 152 | 82 | G1/S transition of mitotic cell cycle | 0.086 | 0.81 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 153 | 5871 | kinesin complex | 0.091 | 0.83 | 1 | 1 | 1 | 0.26 | 1 | 1 |
| 154 | 50794 | regulation of cellular process | 0.091 | 0.83 | 1 | 1 | 1 | 0.26 | 1 | 1 |
| 155 | 7260 | tyrosine phosphorylation of STAT protein | 0.096 | 0.84 | 1 | 1 | 1 | 0.26 | 1 | 1 |
| 156 | 5637 | nuclear inner membrane | 0.096 | 0.84 | 1 | 1 | 1 | 0.26 | 1 | 1 |
| 157 | 5653 | perinuclear space | 0.096 | 0.84 | 1 | 1 | 1 | 0.26 | 1 | 1 |
| 158 | 5623 | cell | 0.098 | 0.84 | 1 | 1 | 1 | 0.27 | 1 | 1 |
| 159 | 18108 | peptidyl-tyrosine phosphorylation | 0.1 | 0.85 | 1 | 1 | 1 | 0.27 | 1 | 1 |
| 160 | 6919 | caspase activation | 0.1 | 0.85 | 1 | 1 | 1 | 0.27 | 1 | 1 |
| 161 | 42127 | regulation of cell proliferation | 0.1 | 0.85 | 1 | 1 | 1 | 0.27 | 1 | 1 |
| 162 | 6733 | oxidoreduction coenzyme metabolism | 0.11 | 0.86 | 1 | 1 | 1 | 0.28 | 1 | 1 |
| 163 | 6306 | DNA methylation | 0.11 | 0.86 | 1 | 1 | 1 | 0.28 | 1 | 1 |
| 164 | 6305 | DNA alkylation | 0.11 | 0.86 | 1 | 1 | 1 | 0.28 | 1 | 1 |
| 165 | 5520 | insulin-like growth factor binding | 0.11 | 0.87 | 1 | 1 | 1 | 0.29 | 1 | 1 |
| 166 | 8139 | nuclear localization sequence binding | 0.11 | 0.87 | 1 | 1 | 1 | 0.29 | 1 | 1 |
| 167 | 18212 | peptidyl-tyrosine modification | 0.11 | 0.87 | 1 | 1 | 1 | 0.29 | 1 | 1 |
| 168 | 793 | condensed chromosome | 0.11 | 0.87 | 1 | 1 | 1 | 0.29 | 1 | 1 |
| 169 | 4674 | protein serine/threonine kinase activity | 0.12 | 0.89 | 1 | 1 | 1 | 0.3 | 1 | 1 |
| 170 | 16010 | dystrophin-associated glycoprotein complex | 0.12 | 0.91 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 171 | 6304 | DNA modification | 0.13 | 0.92 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 172 | 42113 | B-cell activation | 0.13 | 0.92 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 173 | 46907 | intracellular transport | 0.13 | 0.92 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 174 | 6325 | establishment and/or maintenance of chromatin architecture | 0.13 | 0.92 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 175 | 3705 | RNA polymerase II transcription factor activity, enhancer binding | 0.13 | 0.93 | 1 | 1 | 1 | 0.32 | 1 | 1 |
| 176 | 9615 | response to virus | 0.13 | 0.93 | 1 | 1 | 1 | 0.32 | 1 | 1 |
| 177 | 18193 | peptidyl-amino acid modification | 0.14 | 0.94 | 1 | 1 | 1 | 0.33 | 1 | 1 |
| 178 | 7243 | protein kinase cascade | 0.14 | 0.94 | 1 | 1 | 1 | 0.33 | 1 | 1 |
| 179 | 6468 | protein amino acid phosphorylation | 0.14 | 0.94 | 1 | 1 | 1 | 0.33 | 1 | 1 |
| 180 | 6323 | DNA packaging | 0.14 | 0.94 | 1 | 1 | 1 | 0.33 | 1 | 1 |
| 181 | 7389 | pattern specification | 0.14 | 0.94 | 1 | 1 | 1 | 0.33 | 1 | 1 |
| 182 | 46148 | pigment biosynthesis | 0.14 | 0.94 | 1 | 1 | 1 | 0.33 | 1 | 1 |
| 183 | 45893 | positive regulation of transcription, DNA-dependent | 0.14 | 0.94 | 1 | 1 | 1 | 0.33 | 1 | 1 |
| 184 | 42770 | DNA damage response, signal transduction | 0.14 | 0.96 | 1 | 1 | 1 | 0.34 | 1 | 1 |
| 185 | 3887 | DNA-directed DNA polymerase activity | 0.15 | 0.98 | 1 | 1 | 1 | 0.35 | 1 | 1 |
| 186 | 42440 | pigment metabolism | 0.15 | 0.99 | 1 | 1 | 1 | 0.36 | 1 | 1 |
| 187 | 7249 | NIK-I-kappaB/NF-kappaB cascade | 0.15 | 0.99 | 1 | 1 | 1 | 0.36 | 1 | 1 |
| 188 | 5200 | structural constituent of cytoskeleton | 0.16 | 0.99 | 1 | 1 | 1 | 0.36 | 1 | 1 |
| 189 | 12505 | endomembrane system | 0.16 | 1 | 1 | 1 | 1 | 0.37 | 1 | 1 |
| 190 | 188 | inactivation of MAPK | 0.16 | 1 | 1 | 1 | 1 | 0.37 | 1 | 1 |
| 191 | 5605 | basal lamina | 0.16 | 1 | 1 | 1 | 1 | 0.37 | 1 | 1 |
| 192 | 48066 | pigmentation | 0.17 | 1 | 1 | 1 | 1 | 0.38 | 1 | 1 |
| 193 | 30098 | lymphocyte differentiation | 0.17 | 1 | 1 | 1 | 1 | 0.38 | 1 | 1 |
| 194 | 8047 | enzyme activator activity | 0.17 | 1 | 1 | 1 | 1 | 0.38 | 1 | 1 |
| 195 | 8219 | cell death | 0.17 | 1 | 1 | 1 | 1 | 0.38 | 1 | 1 |
| 196 | 16265 | death | 0.18 | 1 | 1 | 1 | 1 | 0.39 | 1 | 1 |
| 197 | 8375 | acetylglucosaminyltransferase activity | 0.18 | 1 | 1 | 1 | 1 | 0.39 | 1 | 1 |
| 198 | 16310 | phosphorylation | 0.18 | 1 | 1 | 1 | 1 | 0.39 | 1 | 1 |
| 199 | 59 | protein-nucleus import, docking | 0.18 | 1 | 1 | 1 | 1 | 0.4 | 1 | 1 |
| 200 | 8277 | regulation of G-protein coupled receptor protein signaling pathway | 0.19 | 1 | 1 | 1 | 1 | 0.41 | 1 | 1 |
| 201 | 3677 | DNA binding | 0.19 | 1 | 1 | 1 | 1 | 0.41 | 1 | 1 |
| 202 | 42445 | hormone metabolism | 0.19 | 1 | 1 | 1 | 1 | 0.41 | 1 | 1 |
| 203 | 46982 | protein heterodimerization activity | 0.19 | 1 | 1 | 1 | 1 | 0.41 | 1 | 1 |
| 204 | 9613 | response to pest/pathogen/parasite | 0.2 | 1 | 1 | 1 | 1 | 0.42 | 1 | 1 |
| 205 | 3702 | RNA polymerase II transcription factor activity | 0.2 | 1 | 1 | 1 | 1 | 0.42 | 1 | 1 |
| 206 | 16049 | cell growth | 0.2 | 1 | 1 | 1 | 1 | 0.42 | 1 | 1 |
| 207 | 6766 | vitamin metabolism | 0.21 | 1 | 1 | 1 | 1 | 0.43 | 1 | 1 |
| 208 | 45941 | positive regulation of transcription | 0.21 | 1 | 1 | 1 | 1 | 0.43 | 1 | 1 |
| 209 | 19897 | extrinsic to plasma membrane | 0.21 | 1 | 1 | 1 | 1 | 0.43 | 1 | 1 |
| 210 | 5737 | cytoplasm | 0.21 | 1 | 1 | 1 | 1 | 0.44 | 1 | 1 |
| 211 | 6974 | response to DNA damage stimulus | 0.22 | 1 | 1 | 1 | 1 | 0.44 | 1 | 1 |
| 212 | 3774 | motor activity | 0.22 | 1 | 1 | 1 | 1 | 0.44 | 1 | 1 |
| 213 | 3704 | specific RNA polymerase II transcription factor activity | 0.22 | 1 | 1 | 1 | 1 | 0.44 | 1 | 1 |
| 214 | 5048 | signal sequence binding | 0.22 | 1 | 1 | 1 | 1 | 0.45 | 1 | 1 |
| 215 | 6950 | response to stress | 0.22 | 1 | 1 | 1 | 1 | 0.45 | 1 | 1 |
| 216 | 9719 | response to endogenous stimulus | 0.22 | 1 | 1 | 1 | 1 | 0.45 | 1 | 1 |
| 217 | 8094 | DNA dependent ATPase activity | 0.23 | 1 | 1 | 1 | 1 | 0.45 | 1 | 1 |
| 218 | 8632 | apoptotic program | 0.23 | 1 | 1 | 1 | 1 | 0.45 | 1 | 1 |
| 219 | 151 | ubiquitin ligase complex | 0.23 | 1 | 1 | 1 | 1 | 0.46 | 1 | 1 |
| 220 | 6487 | N-linked glycosylation | 0.23 | 1 | 1 | 1 | 1 | 0.46 | 1 | 1 |
| 221 | 3793 | defense/immunity protein activity | 0.24 | 1 | 1 | 1 | 1 | 0.46 | 1 | 1 |
| 222 | 5575 | cellular_component | 0.24 | 1 | 1 | 1 | 1 | 0.46 | 1 | 1 |
| 223 | 3684 | damaged DNA binding | 0.24 | 1 | 1 | 1 | 1 | 0.47 | 1 | 1 |
| 224 | 8305 | integrin complex | 0.25 | 1 | 1 | 1 | 1 | 0.48 | 1 | 1 |
| 225 | 42379 | chemokine receptor binding | 0.25 | 1 | 1 | 1 | 1 | 0.48 | 1 | 1 |
| 226 | 8009 | chemokine activity | 0.25 | 1 | 1 | 1 | 1 | 0.48 | 1 | 1 |
| 227 | 1664 | G-protein-coupled receptor binding | 0.25 | 1 | 1 | 1 | 1 | 0.48 | 1 | 1 |
| 228 | 19838 | growth factor binding | 0.25 | 1 | 1 | 1 | 1 | 0.48 | 1 | 1 |
| 229 | 42056 | chemoattractant activity | 0.26 | 1 | 1 | 1 | 1 | 0.49 | 1 | 1 |
| 230 | 19955 | cytokine binding | 0.26 | 1 | 1 | 1 | 1 | 0.49 | 1 | 1 |
| 231 | 4672 | protein kinase activity | 0.26 | 1 | 1 | 1 | 1 | 0.49 | 1 | 1 |
| 232 | 19898 | extrinsic to membrane | 0.27 | 1 | 1 | 1 | 1 | 0.51 | 1 | 1 |
| 233 | 40029 | regulation of gene expression, epigenetic | 0.27 | 1 | 1 | 1 | 1 | 0.51 | 1 | 1 |
| 234 | 30695 | GTPase regulator activity | 0.28 | 1 | 1 | 1 | 1 | 0.53 | 1 | 1 |
| 235 | 46649 | lymphocyte activation | 0.29 | 1 | 1 | 1 | 1 | 0.53 | 1 | 1 |
| 236 | 4386 | helicase activity | 0.29 | 1 | 1 | 1 | 1 | 0.54 | 1 | 1 |
| 237 | 7242 | intracellular signaling cascade | 0.29 | 1 | 1 | 1 | 1 | 0.54 | 1 | 1 |
| 238 | 6351 | transcription, DNA-dependent | 0.3 | 1 | 1 | 1 | 1 | 0.54 | 1 | 1 |
| 239 | 3754 | chaperone activity | 0.3 | 1 | 1 | 1 | 1 | 0.54 | 1 | 1 |
| 240 | 7229 | integrin-mediated signaling pathway | 0.3 | 1 | 1 | 1 | 1 | 0.54 | 1 | 1 |
| 241 | 4895 | cell adhesion receptor activity | 0.3 | 1 | 1 | 1 | 1 | 0.54 | 1 | 1 |
| 242 | 46983 | protein dimerization activity | 0.3 | 1 | 1 | 1 | 1 | 0.54 | 1 | 1 |
| 243 | 7264 | small GTPase mediated signal transduction | 0.31 | 1 | 1 | 1 | 1 | 0.55 | 1 | 1 |
| 244 | 30097 | hemopoiesis | 0.31 | 1 | 1 | 1 | 1 | 0.55 | 1 | 1 |
| 245 | 9607 | response to biotic stimulus | 0.31 | 1 | 1 | 1 | 1 | 0.56 | 1 | 1 |
| 246 | 7398 | ectoderm development | 0.32 | 1 | 1 | 1 | 1 | 0.56 | 1 | 1 |
| 247 | 5198 | structural molecule activity | 0.33 | 1 | 1 | 1 | 1 | 0.58 | 1 | 1 |
| 248 | 3713 | transcription coactivator activity | 0.33 | 1 | 1 | 1 | 1 | 0.58 | 1 | 1 |
| 249 | 5515 | protein binding | 0.33 | 1 | 1 | 1 | 1 | 0.58 | 1 | 1 |
| 250 | 5604 | basement membrane | 0.34 | 1 | 1 | 1 | 1 | 0.58 | 1 | 1 |
| 251 | 1775 | cell activation | 0.34 | 1 | 1 | 1 | 1 | 0.58 | 1 | 1 |
| 252 | 4896 | hematopoietin/interferon-class (D200-domain) cytokine receptor activity | 0.34 | 1 | 1 | 1 | 1 | 0.58 | 1 | 1 |
| 253 | 45321 | immune cell activation | 0.34 | 1 | 1 | 1 | 1 | 0.58 | 1 | 1 |
| 254 | 5083 | small GTPase regulatory/interacting protein activity | 0.34 | 1 | 1 | 1 | 1 | 0.58 | 1 | 1 |
| 255 | 6793 | phosphorus metabolism | 0.34 | 1 | 1 | 1 | 1 | 0.58 | 1 | 1 |
| 256 | 6796 | phosphate metabolism | 0.34 | 1 | 1 | 1 | 1 | 0.58 | 1 | 1 |
| 257 | 6350 | transcription | 0.35 | 1 | 1 | 1 | 1 | 0.59 | 1 | 1 |
| 258 | 46930 | pore complex | 0.35 | 1 | 1 | 1 | 1 | 0.59 | 1 | 1 |
| 259 | 5643 | nuclear pore | 0.35 | 1 | 1 | 1 | 1 | 0.59 | 1 | 1 |
| 260 | 6355 | regulation of transcription, DNA-dependent | 0.36 | 1 | 1 | 1 | 1 | 0.6 | 1 | 1 |
| 261 | 30234 | enzyme regulator activity | 0.36 | 1 | 1 | 1 | 1 | 0.6 | 1 | 1 |
| 262 | 165 | MAPKKK cascade | 0.36 | 1 | 1 | 1 | 1 | 0.6 | 1 | 1 |
| 263 | 6139 | nucleobase, nucleoside, nucleotide and nucleic acid metabolism | 0.37 | 1 | 1 | 1 | 1 | 0.61 | 1 | 1 |
| 264 | 6281 | DNA repair | 0.37 | 1 | 1 | 1 | 1 | 0.61 | 1 | 1 |
| 265 | 16773 | phosphotransferase activity, alcohol group as acceptor | 0.38 | 1 | 1 | 1 | 1 | 0.61 | 1 | 1 |
| 266 | 30528 | transcription regulator activity | 0.38 | 1 | 1 | 1 | 1 | 0.61 | 1 | 1 |
| 267 | 4497 | monooxygenase activity | 0.38 | 1 | 1 | 1 | 1 | 0.61 | 1 | 1 |
| 268 | 9108 | coenzyme biosynthesis | 0.38 | 1 | 1 | 1 | 1 | 0.61 | 1 | 1 |
| 269 | 4857 | enzyme inhibitor activity | 0.38 | 1 | 1 | 1 | 1 | 0.61 | 1 | 1 |
| 270 | 16563 | transcriptional activator activity | 0.38 | 1 | 1 | 1 | 1 | 0.61 | 1 | 1 |
| 271 | 8369 | obsolete molecular function | 0.39 | 1 | 1 | 1 | 1 | 0.62 | 1 | 1 |
| 272 | 46821 | extrachromosomal DNA | 0.39 | 1 | 1 | 1 | 1 | 0.63 | 1 | 1 |
| 273 | 45449 | regulation of transcription | 0.39 | 1 | 1 | 1 | 1 | 0.63 | 1 | 1 |
| 274 | 6606 | protein-nucleus import | 0.4 | 1 | 1 | 1 | 1 | 0.63 | 1 | 1 |
| 275 | 4009 | ATP-binding cassette (ABC) transporter activity | 0.4 | 1 | 1 | 1 | 1 | 0.63 | 1 | 1 |
| 276 | 6464 | protein modification | 0.41 | 1 | 1 | 1 | 1 | 0.63 | 1 | 1 |
| 277 | 4840 | ubiquitin conjugating enzyme activity | 0.41 | 1 | 1 | 1 | 1 | 0.63 | 1 | 1 |
| 278 | 9888 | histogenesis | 0.41 | 1 | 1 | 1 | 1 | 0.63 | 1 | 1 |
| 279 | 16772 | transferase activity, transferring phosphorus-containing groups | 0.41 | 1 | 1 | 1 | 1 | 0.63 | 1 | 1 |
| 280 | 8639 | small protein conjugating enzyme activity | 0.42 | 1 | 1 | 1 | 1 | 0.65 | 1 | 1 |
| 281 | 5057 | receptor signaling protein activity | 0.42 | 1 | 1 | 1 | 1 | 0.66 | 1 | 1 |
| 282 | 4295 | trypsin activity | 0.44 | 1 | 1 | 1 | 1 | 0.67 | 1 | 1 |
| 283 | 7160 | cell-matrix adhesion | 0.44 | 1 | 1 | 1 | 1 | 0.67 | 1 | 1 |
| 284 | 6445 | regulation of translation | 0.44 | 1 | 1 | 1 | 1 | 0.67 | 1 | 1 |
| 285 | 6366 | transcription from Pol II promoter | 0.44 | 1 | 1 | 1 | 1 | 0.67 | 1 | 1 |
| 286 | 6261 | DNA dependent DNA replication | 0.44 | 1 | 1 | 1 | 1 | 0.67 | 1 | 1 |
| 287 | 45786 | negative regulation of cell cycle | 0.44 | 1 | 1 | 1 | 1 | 0.67 | 1 | 1 |
| 288 | 7582 | physiological process | 0.45 | 1 | 1 | 1 | 1 | 0.67 | 1 | 1 |
| 289 | 5654 | nucleoplasm | 0.45 | 1 | 1 | 1 | 1 | 0.67 | 1 | 1 |
| 290 | 46138 | coenzyme and prosthetic group biosynthesis | 0.45 | 1 | 1 | 1 | 1 | 0.67 | 1 | 1 |
| 291 | 6935 | chemotaxis | 0.45 | 1 | 1 | 1 | 1 | 0.67 | 1 | 1 |
| 292 | 42330 | taxis | 0.45 | 1 | 1 | 1 | 1 | 0.67 | 1 | 1 |
| 293 | 3700 | transcription factor activity | 0.46 | 1 | 1 | 1 | 1 | 0.67 | 1 | 1 |
| 294 | 16616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 0.46 | 1 | 1 | 1 | 1 | 0.67 | 1 | 1 |
| 295 | 7596 | blood coagulation | 0.46 | 1 | 1 | 1 | 1 | 0.67 | 1 | 1 |
| 296 | 50817 | coagulation | 0.46 | 1 | 1 | 1 | 1 | 0.67 | 1 | 1 |
| 297 | 7283 | spermatogenesis | 0.46 | 1 | 1 | 1 | 1 | 0.67 | 1 | 1 |
| 298 | 48232 | male gamete generation | 0.46 | 1 | 1 | 1 | 1 | 0.67 | 1 | 1 |
| 299 | 1558 | regulation of cell growth | 0.47 | 1 | 1 | 1 | 1 | 0.68 | 1 | 1 |
| 300 | 16614 | oxidoreductase activity, acting on CH-OH group of donors | 0.48 | 1 | 1 | 1 | 1 | 0.69 | 1 | 1 |
| 301 | 16055 | Wnt receptor signaling pathway | 0.48 | 1 | 1 | 1 | 1 | 0.69 | 1 | 1 |
| 302 | 7599 | hemostasis | 0.48 | 1 | 1 | 1 | 1 | 0.69 | 1 | 1 |
| 303 | 42277 | peptide binding | 0.48 | 1 | 1 | 1 | 1 | 0.69 | 1 | 1 |
| 304 | 45892 | negative regulation of transcription, DNA-dependent | 0.48 | 1 | 1 | 1 | 1 | 0.69 | 1 | 1 |
| 305 | 16779 | nucleotidyltransferase activity | 0.49 | 1 | 1 | 1 | 1 | 0.69 | 1 | 1 |
| 306 | 8168 | methyltransferase activity | 0.49 | 1 | 1 | 1 | 1 | 0.69 | 1 | 1 |
| 307 | 6486 | protein amino acid glycosylation | 0.5 | 1 | 1 | 1 | 1 | 0.7 | 1 | 1 |
| 308 | 16741 | transferase activity, transferring one-carbon groups | 0.5 | 1 | 1 | 1 | 1 | 0.71 | 1 | 1 |
| 309 | 9581 | perception of external stimulus | 0.51 | 1 | 1 | 1 | 1 | 0.71 | 1 | 1 |
| 310 | 9101 | glycoprotein biosynthesis | 0.51 | 1 | 1 | 1 | 1 | 0.71 | 1 | 1 |
| 311 | 6732 | coenzyme metabolism | 0.51 | 1 | 1 | 1 | 1 | 0.72 | 1 | 1 |
| 312 | 6725 | aromatic compound metabolism | 0.52 | 1 | 1 | 1 | 1 | 0.72 | 1 | 1 |
| 313 | 6913 | nucleocytoplasmic transport | 0.52 | 1 | 1 | 1 | 1 | 0.72 | 1 | 1 |
| 314 | 5102 | receptor binding | 0.52 | 1 | 1 | 1 | 1 | 0.72 | 1 | 1 |
| 315 | 12501 | programmed cell death | 0.52 | 1 | 1 | 1 | 1 | 0.72 | 1 | 1 |
| 316 | 6915 | apoptosis | 0.52 | 1 | 1 | 1 | 1 | 0.72 | 1 | 1 |
| 317 | 7276 | gametogenesis | 0.53 | 1 | 1 | 1 | 1 | 0.72 | 1 | 1 |
| 318 | 8284 | positive regulation of cell proliferation | 0.53 | 1 | 1 | 1 | 1 | 0.72 | 1 | 1 |
| 319 | 16758 | transferase activity, transferring hexosyl groups | 0.53 | 1 | 1 | 1 | 1 | 0.72 | 1 | 1 |
| 320 | 9100 | glycoprotein metabolism | 0.54 | 1 | 1 | 1 | 1 | 0.73 | 1 | 1 |
| 321 | 16853 | isomerase activity | 0.54 | 1 | 1 | 1 | 1 | 0.74 | 1 | 1 |
| 322 | 4252 | serine-type endopeptidase activity | 0.55 | 1 | 1 | 1 | 1 | 0.74 | 1 | 1 |
| 323 | 16301 | kinase activity | 0.55 | 1 | 1 | 1 | 1 | 0.74 | 1 | 1 |
| 324 | 6357 | regulation of transcription from Pol II promoter | 0.56 | 1 | 1 | 1 | 1 | 0.74 | 1 | 1 |
| 325 | 8150 | biological_process | 0.56 | 1 | 1 | 1 | 1 | 0.74 | 1 | 1 |
| 326 | 6955 | immune response | 0.56 | 1 | 1 | 1 | 1 | 0.74 | 1 | 1 |
| 327 | 4842 | ubiquitin-protein ligase activity | 0.56 | 1 | 1 | 1 | 1 | 0.75 | 1 | 1 |
| 328 | 19953 | sexual reproduction | 0.57 | 1 | 1 | 1 | 1 | 0.75 | 1 | 1 |
| 329 | 3 | reproduction | 0.57 | 1 | 1 | 1 | 1 | 0.75 | 1 | 1 |
| 330 | 4713 | protein-tyrosine kinase activity | 0.57 | 1 | 1 | 1 | 1 | 0.75 | 1 | 1 |
| 331 | 6731 | coenzyme and prosthetic group metabolism | 0.58 | 1 | 1 | 1 | 1 | 0.75 | 1 | 1 |
| 332 | 5488 | binding | 0.58 | 1 | 1 | 1 | 1 | 0.75 | 1 | 1 |
| 333 | 7517 | muscle development | 0.58 | 1 | 1 | 1 | 1 | 0.75 | 1 | 1 |
| 334 | 5554 | molecular_function unknown | 0.58 | 1 | 1 | 1 | 1 | 0.75 | 1 | 1 |
| 335 | 16820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances | 0.59 | 1 | 1 | 1 | 1 | 0.75 | 1 | 1 |
| 336 | 42626 | ATPase activity, coupled to transmembrane movement of substances | 0.59 | 1 | 1 | 1 | 1 | 0.75 | 1 | 1 |
| 337 | 8236 | serine-type peptidase activity | 0.59 | 1 | 1 | 1 | 1 | 0.75 | 1 | 1 |
| 338 | 42623 | ATPase activity, coupled | 0.59 | 1 | 1 | 1 | 1 | 0.75 | 1 | 1 |
| 339 | 3924 | GTPase activity | 0.59 | 1 | 1 | 1 | 1 | 0.75 | 1 | 1 |
| 340 | 7601 | vision | 0.59 | 1 | 1 | 1 | 1 | 0.76 | 1 | 1 |
| 341 | 16481 | negative regulation of transcription | 0.6 | 1 | 1 | 1 | 1 | 0.76 | 1 | 1 |
| 342 | 9583 | perception of light | 0.61 | 1 | 1 | 1 | 1 | 0.77 | 1 | 1 |
| 343 | 6952 | defense response | 0.61 | 1 | 1 | 1 | 1 | 0.77 | 1 | 1 |
| 344 | 8234 | cysteine-type peptidase activity | 0.61 | 1 | 1 | 1 | 1 | 0.77 | 1 | 1 |
| 345 | 9605 | response to external stimulus | 0.61 | 1 | 1 | 1 | 1 | 0.77 | 1 | 1 |
| 346 | 6954 | inflammatory response | 0.62 | 1 | 1 | 1 | 1 | 0.77 | 1 | 1 |
| 347 | 3712 | transcription cofactor activity | 0.62 | 1 | 1 | 1 | 1 | 0.77 | 1 | 1 |
| 348 | 9416 | response to light | 0.62 | 1 | 1 | 1 | 1 | 0.77 | 1 | 1 |
| 349 | 16887 | ATPase activity | 0.62 | 1 | 1 | 1 | 1 | 0.77 | 1 | 1 |
| 350 | 15405 | P-P-bond-hydrolysis-driven transporter activity | 0.63 | 1 | 1 | 1 | 1 | 0.77 | 1 | 1 |
| 351 | 45087 | innate immune response | 0.63 | 1 | 1 | 1 | 1 | 0.77 | 1 | 1 |
| 352 | 8026 | ATP dependent helicase activity | 0.63 | 1 | 1 | 1 | 1 | 0.77 | 1 | 1 |
| 353 | 19941 | modification-dependent protein catabolism | 0.63 | 1 | 1 | 1 | 1 | 0.77 | 1 | 1 |
| 354 | 6511 | ubiquitin-dependent protein catabolism | 0.63 | 1 | 1 | 1 | 1 | 0.77 | 1 | 1 |
| 355 | 6605 | protein targeting | 0.63 | 1 | 1 | 1 | 1 | 0.77 | 1 | 1 |
| 356 | 5125 | cytokine activity | 0.63 | 1 | 1 | 1 | 1 | 0.77 | 1 | 1 |
| 357 | 16817 | hydrolase activity, acting on acid anhydrides | 0.63 | 1 | 1 | 1 | 1 | 0.77 | 1 | 1 |
| 358 | 6512 | ubiquitin cycle | 0.64 | 1 | 1 | 1 | 1 | 0.77 | 1 | 1 |
| 359 | 16881 | acid-D-amino acid ligase activity | 0.64 | 1 | 1 | 1 | 1 | 0.78 | 1 | 1 |
| 360 | 16740 | transferase activity | 0.65 | 1 | 1 | 1 | 1 | 0.78 | 1 | 1 |
| 361 | 4 | biological_process unknown | 0.65 | 1 | 1 | 1 | 1 | 0.78 | 1 | 1 |
| 362 | 8134 | transcription factor binding | 0.65 | 1 | 1 | 1 | 1 | 0.78 | 1 | 1 |
| 363 | 7165 | signal transduction | 0.67 | 1 | 1 | 1 | 1 | 0.8 | 1 | 1 |
| 364 | 9314 | response to radiation | 0.68 | 1 | 1 | 1 | 1 | 0.81 | 1 | 1 |
| 365 | 5794 | Golgi apparatus | 0.68 | 1 | 1 | 1 | 1 | 0.81 | 1 | 1 |
| 366 | 16818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 0.69 | 1 | 1 | 1 | 1 | 0.81 | 1 | 1 |
| 367 | 30154 | cell differentiation | 0.69 | 1 | 1 | 1 | 1 | 0.82 | 1 | 1 |
| 368 | 16757 | transferase activity, transferring glycosyl groups | 0.69 | 1 | 1 | 1 | 1 | 0.82 | 1 | 1 |
| 369 | 43037 | translation | 0.7 | 1 | 1 | 1 | 1 | 0.82 | 1 | 1 |
| 370 | 8565 | protein transporter activity | 0.7 | 1 | 1 | 1 | 1 | 0.82 | 1 | 1 |
| 371 | 42221 | response to chemical substance | 0.72 | 1 | 1 | 1 | 1 | 0.84 | 1 | 1 |
| 372 | 3925 | small monomeric GTPase activity | 0.73 | 1 | 1 | 1 | 1 | 0.85 | 1 | 1 |
| 373 | 6508 | proteolysis and peptidolysis | 0.73 | 1 | 1 | 1 | 1 | 0.85 | 1 | 1 |
| 374 | 16879 | ligase activity, forming carbon-nitrogen bonds | 0.73 | 1 | 1 | 1 | 1 | 0.85 | 1 | 1 |
| 375 | 7267 | cell-cell signaling | 0.74 | 1 | 1 | 1 | 1 | 0.86 | 1 | 1 |
| 376 | 8372 | cellular_component unknown | 0.74 | 1 | 1 | 1 | 1 | 0.86 | 1 | 1 |
| 377 | 30163 | protein catabolism | 0.75 | 1 | 1 | 1 | 1 | 0.86 | 1 | 1 |
| 378 | 5625 | soluble fraction | 0.75 | 1 | 1 | 1 | 1 | 0.86 | 1 | 1 |
| 379 | 3676 | nucleic acid binding | 0.76 | 1 | 1 | 1 | 1 | 0.87 | 1 | 1 |
| 380 | 9611 | response to wounding | 0.76 | 1 | 1 | 1 | 1 | 0.87 | 1 | 1 |
| 381 | 15399 | primary active transporter activity | 0.76 | 1 | 1 | 1 | 1 | 0.87 | 1 | 1 |
| 382 | 9057 | macromolecule catabolism | 0.77 | 1 | 1 | 1 | 1 | 0.87 | 1 | 1 |
| 383 | 4871 | signal transducer activity | 0.77 | 1 | 1 | 1 | 1 | 0.87 | 1 | 1 |
| 384 | 8270 | zinc ion binding | 0.78 | 1 | 1 | 1 | 1 | 0.88 | 1 | 1 |
| 385 | 7275 | development | 0.78 | 1 | 1 | 1 | 1 | 0.88 | 1 | 1 |
| 386 | 3779 | actin binding | 0.78 | 1 | 1 | 1 | 1 | 0.88 | 1 | 1 |
| 387 | 9582 | perception of abiotic stimulus | 0.79 | 1 | 1 | 1 | 1 | 0.88 | 1 | 1 |
| 388 | 7600 | sensory perception | 0.79 | 1 | 1 | 1 | 1 | 0.89 | 1 | 1 |
| 389 | 4175 | endopeptidase activity | 0.81 | 1 | 1 | 1 | 1 | 0.9 | 1 | 1 |
| 390 | 9628 | response to abiotic stimulus | 0.81 | 1 | 1 | 1 | 1 | 0.9 | 1 | 1 |
| 391 | 7166 | cell surface receptor linked signal transduction | 0.81 | 1 | 1 | 1 | 1 | 0.9 | 1 | 1 |
| 392 | 5194 | cell adhesion molecule activity | 0.82 | 1 | 1 | 1 | 1 | 0.91 | 1 | 1 |
| 393 | 5578 | extracellular matrix | 0.83 | 1 | 1 | 1 | 1 | 0.92 | 1 | 1 |
| 394 | 50800 | hydrolase activity, acting on acid anhydrides, acting on GTP, involved in cellular and subcellular movement | 0.83 | 1 | 1 | 1 | 1 | 0.92 | 1 | 1 |
| 395 | 9653 | morphogenesis | 0.85 | 1 | 1 | 1 | 1 | 0.93 | 1 | 1 |
| 396 | 8092 | cytoskeletal protein binding | 0.85 | 1 | 1 | 1 | 1 | 0.93 | 1 | 1 |
| 397 | 6886 | intracellular protein transport | 0.85 | 1 | 1 | 1 | 1 | 0.93 | 1 | 1 |
| 398 | 6412 | protein biosynthesis | 0.86 | 1 | 1 | 1 | 1 | 0.94 | 1 | 1 |
| 399 | 5829 | cytosol | 0.86 | 1 | 1 | 1 | 1 | 0.94 | 1 | 1 |
| 400 | 19538 | protein metabolism | 0.86 | 1 | 1 | 1 | 1 | 0.94 | 1 | 1 |
| 401 | 16874 | ligase activity | 0.87 | 1 | 1 | 1 | 1 | 0.94 | 1 | 1 |
| 402 | 8233 | peptidase activity | 0.87 | 1 | 1 | 1 | 1 | 0.94 | 1 | 1 |
| 403 | 46914 | transition metal ion binding | 0.88 | 1 | 1 | 1 | 1 | 0.94 | 1 | 1 |
| 404 | 15031 | protein transport | 0.88 | 1 | 1 | 1 | 1 | 0.94 | 1 | 1 |
| 405 | 6118 | electron transport | 0.89 | 1 | 1 | 1 | 1 | 0.95 | 1 | 1 |
| 406 | 5576 | extracellular | 0.89 | 1 | 1 | 1 | 1 | 0.95 | 1 | 1 |
| 407 | 16491 | oxidoreductase activity | 0.89 | 1 | 1 | 1 | 1 | 0.95 | 1 | 1 |
| 408 | 9887 | organogenesis | 0.9 | 1 | 1 | 1 | 1 | 0.96 | 1 | 1 |
| 409 | 6810 | transport | 0.91 | 1 | 1 | 1 | 1 | 0.96 | 1 | 1 |
| 410 | 7155 | cell adhesion | 0.91 | 1 | 1 | 1 | 1 | 0.96 | 1 | 1 |
| 411 | 5975 | carbohydrate metabolism | 0.91 | 1 | 1 | 1 | 1 | 0.96 | 1 | 1 |
| 412 | 9056 | catabolism | 0.91 | 1 | 1 | 1 | 1 | 0.96 | 1 | 1 |
| 413 | 9058 | biosynthesis | 0.92 | 1 | 1 | 1 | 1 | 0.96 | 1 | 1 |
| 414 | 4872 | receptor activity | 0.92 | 1 | 1 | 1 | 1 | 0.97 | 1 | 1 |
| 415 | 7186 | G-protein coupled receptor protein signaling pathway | 0.93 | 1 | 1 | 1 | 1 | 0.97 | 1 | 1 |
| 416 | 7154 | cell communication | 0.93 | 1 | 1 | 1 | 1 | 0.97 | 1 | 1 |
| 417 | 5386 | carrier activity | 0.94 | 1 | 1 | 1 | 1 | 0.98 | 1 | 1 |
| 418 | 5783 | endoplasmic reticulum | 0.94 | 1 | 1 | 1 | 1 | 0.98 | 1 | 1 |
| 419 | 5886 | plasma membrane | 0.96 | 1 | 1 | 1 | 1 | 0.99 | 1 | 1 |
| 420 | 5887 | integral to plasma membrane | 0.96 | 1 | 1 | 1 | 1 | 0.99 | 1 | 1 |
| 421 | 267 | cell fraction | 0.96 | 1 | 1 | 1 | 1 | 0.99 | 1 | 1 |
| 422 | 8152 | metabolism | 0.97 | 1 | 1 | 1 | 1 | 0.99 | 1 | 1 |
| 423 | 5509 | calcium ion binding | 0.97 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 424 | 5624 | membrane fraction | 0.98 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 425 | 9059 | macromolecule biosynthesis | 0.98 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 426 | 4888 | transmembrane receptor activity | 0.98 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 427 | 46872 | metal ion binding | 0.99 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 428 | 16787 | hydrolase activity | 0.99 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 429 | 16021 | integral to membrane | 0.99 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 430 | 3824 | catalytic activity | 0.99 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 431 | 5215 | transporter activity | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 432 | 16020 | membrane | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 433 | 3674 | molecular_function | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 434 | 3673 | Gene_Ontology | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| | Number of significant terms | 127 | 51 | 25 | 24 | 24 | 72 | 32 | 24 |